West Nile virus infection and immunity (Q38074266)

28 August 2017

1 reference

title

West Nile virus infection and immunity (English)

1 reference

28 August 2017

0 references

2

Michael S Diamond

0 references

Michael Gale

object named as

Michael Gale

series ordinal

3

0 references

Mehul S. Suthar

series ordinal

1

object named as

Mehul S Suthar

1 reference

PubMed ID

23321534

28 August 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

Nature Reviews Microbiology

28 August 2017

1 reference

28 August 2017

11

1 reference

28 August 2017

115-128

1 reference

28 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro2950

28 August 2017

0 references

cites work

The molecular biology of West Nile Virus: a new invader of the western hemisphere

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A global perspective on the epidemiology of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Nonviremic transmission of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Alligators as West Nile virus amplifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus dissemination and tissue tropisms in orally infected Culex pipiens quinquefasciatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Peritrophic matrix proteins of Anopheles gambiae and Aedes aegypti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Innate immune control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The native Wolbachia endosymbionts of Drosophila melanogaster and Culex quinquefasciatus increase host resistance to West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Potentiation of West Nile encephalitis by mosquito feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Mosquito saliva causes enhancement of West Nile virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Keratinocytes are cell targets of West Nile virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A paradoxical role for neutrophils in the pathogenesis of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Matrix Metalloproteinase 9 Facilitates West Nile Virus Entry into the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

IPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Virus interference. I. The interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Duration of protective action of interferon against infection with West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Immune signaling by RIG-I-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Establishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Activation of RIG-I-like receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Subcellular localization of Toll-like receptor 3 in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Toll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and Homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

IRF-7 is the master regulator of type-I interferon-dependent immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The Jak-STAT pathway stimulated by interferon alpha or interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Induction of IFN-β and the Innate Antiviral Response in Myeloid Cells Occurs through an IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Positional cloning of the murine flavivirus resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Host genetic risk factors for West Nile virus infection and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

RNase L plays a role in the antiviral response to West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A diverse range of gene products are effectors of the type I interferon antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Cell-intrinsic innate immune control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Modulation of inflammasome pathways by bacterial and viral pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Resistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and Virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus infection induces depletion of IFNAR1 protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Cholesterol manipulation by West Nile virus perturbs the cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Differential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A Single Amino Acid Substitution in the West Nile Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit Alpha/Beta Interferon Induction and Attenuates Virus Virulence in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The ISG56/IFIT1 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Complement and viral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Modulation of natural killer cell activity by viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Anti-West Nile virus activity of in vitro expanded human primary natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Pathologic and immunohistochemical findings in naturally occuring West Nile virus infection in horses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Role of two distinct γδ T cell subsets during West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Complement activation is required for induction of a protective antibody response against West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Protective immune responses against West Nile virus are primed by distinct complement activation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The lectin pathway of complement activation contributes to protection from West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Role of CD8+ T cells in control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Fas Ligand Interactions Contribute to CD8+ T-Cell-Mediated Control of West Nile Virus Infection in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A live, attenuated recombinant West Nile virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Use of defined TLR ligands as adjuvants within human vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus isolates from India: evidence for a distinct genetic lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West Nile virus lineage 2 from blood donor, Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Novel flavivirus or new lineage of West Nile virus, central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Neurologic manifestations and outcome of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Activation of MDA5 requires higher-order RNA structures generated during virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Visualisation of direct interaction of MDA5 and the dsRNA replicative intermediate form of positive strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Experimental infection of fox squirrels (Sciurus niger) with West Nile virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2950

West nile virus disease and other arboviral diseases - United States, 2011.

31 March 2020

1 reference

12 December 2020

West Nile virus in Europe: understanding the present to gauge the future

1 reference

12 December 2020

West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations.

1 reference

12 December 2020

The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission

1 reference

12 December 2020

Tregs control the development of symptomatic West Nile virus infection in humans and mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2950

1 reference

PubMed ID

23321534

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23321534